Drug Information

Drug General Information
Drug ID
D05XKT
Former ID
DNC007898
Drug Name
1,2-dihydro-2-oxoquinazoline-4-carboxyanilide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529186]
Formula
C15H11N3O2
Canonical SMILES
C1=CC=C(C=C1)NC(=O)C2=NC(=O)NC3=CC=CC=C32
InChI
1S/C15H11N3O2/c19-14(16-10-6-2-1-3-7-10)13-11-8-4-5-9-12(11)17-15(20)18-13/h1-9H,(H,16,19)(H,17,18,20)
InChIKey
IBKXBRUBWALIOJ-UHFFFAOYSA-N
PubChem Compound ID
24749598
Target and Pathway
Target(s) Adenosine A3 receptor Target Info Inhibitor [529186]
Reactome Adenosine P1 receptors
G alpha (i) signalling events
WikiPathways Nucleotide GPCRs
GPCRs, Class A Rhodopsin-like
GPCRs, Other
References
Ref 529186J Med Chem. 2007 Dec 27;50(26):6596-606. Epub 2007 Nov 30.Scouting human A3 adenosine receptor antagonist binding mode using a molecular simplification approach: from triazoloquinoxaline to a pyrimidine skeleton as a key study.
Ref 529186J Med Chem. 2007 Dec 27;50(26):6596-606. Epub 2007 Nov 30.Scouting human A3 adenosine receptor antagonist binding mode using a molecular simplification approach: from triazoloquinoxaline to a pyrimidine skeleton as a key study.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.